Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced that it has applied the CE mark to PGDx elio™ plasma resolve. It is the first kitted plasma-based NGS oncology test to have that certification, enabling greater access to genomic testing for cancer patients in Europe.
{iframe}https://www.biospace.com/article/releases/personal-genome-diagnostics-ce-marks-liquid-biopsy-test/{/iframe}